Figure 1.
Correlation of ZAP-70 expression with IgVH mutational status. Sixty-five percent of patients with mutated IgVH gene were ZAP-70– as assessed by flow cytometry and 100% of patients with unmutated IgVH genes were ZAP-70+. Twenty-six percent of patients were ZAP-70+ and mutated, of these patients the majority had additional bad prognostic markers (ie, CD38 positivity or unfavorable IgVH gene usage; Table 1).